Company news

Genomtec SA news in 2025

Genomtec SA's news releases, calls and decks from 2025, newest first.

View company

GMT: Net loss persists as R&D spending rises; commercialization and funding remain critical

November 28, 2025

GMT: Net loss deepened to PLN 6.6M as R&D spending rose; commercialization still ahead

September 29, 2025

GMT: Genomtec's Q1 2025 loss widened as R&D ramped up, with commercialization still pending

May 29, 2025

GMT: Rapid genetic diagnostics, strong IP, and robust funding drive growth and M&A momentum

May 14, 2025

GMT: Net loss widened to PLN -11.2m as R&D continued, with equity raises ensuring 12+ months liquidity

April 29, 2025

Decks in 2025